Christopher Robinson/LinkedIn
Jul 4, 2026, 07:43
Christopher Robinson: Nipocalimab Phase 3 Trials in Fetal and Neonatal Alloimmune Thrombocytopenia
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“Design of the Phase 3 FREESIA-1 and FREESIA-3 Trials of Nipocalimab in Fetal and Neonatal Alloimmune Thrombocytopenia – Development of FNAIT․”
Title: Plain Language Summary of Publication: Design of the Phase 3 FREESIA-1 and FREESIA-3 Trials of Nipocalimab in Fetal and Neonatal Alloimmune Thrombocytopenia
Authors: Pamela Baker, Babajide Keshinro, Barbara Stegmann, Abbie Oey, Cathye Shu, Dirk Heerwegh, Rebecca Zaha, Hillary Van Valkenburgh
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 23, 2026, 17:19Oluyemisi Famuyiwa: Financing Your Fertility Treatment
-
Aug 23, 2026, 17:11Favour Ayomi: The Questions That Changed Reproductive Science
-
Aug 23, 2026, 16:54Chang-Hoon Cho: A Comprehensive Immune Atlas of the Human Endometrium
-
Aug 23, 2026, 16:42Sharing Shannon’s Story with Preeclampsia This Story Saturday – Preeclampsia Foundation
-
Aug 23, 2026, 16:36Sarah Lewen: The More Capable the Machines Become, the More Human Connection Matters
-
Aug 23, 2026, 16:31Chandana A։ Why Good-Quality Embryos Sometimes Don’t Implant
-
Aug 23, 2026, 16:28Negin Asadi։ How Does the Blastocyst Attach to the Uterus?
-
Aug 23, 2026, 16:22Christopher Robinson։ Ultrasound Images of Scar and Cesarean Scar Defects
-
Aug 23, 2026, 16:17Somya Jha։ ICSI – 1 Sperm, 1 Egg, 1 Tiny Needle